Slide CEO sells 227,987 shares under 10b5-1 plan

Slide Insurance Holdings, Inc. director and CEO Lucas Bruce reported an open-market sale of common stock by an entity he controls.

Rhea-AI Filing Summary

Slide Insurance Holdings, Inc. director and CEO Lucas Bruce reported an open-market sale of common stock by an entity he controls. IIM Holdings II, LLC sold 227,987 shares of Slide Insurance at a weighted average price of $18.95 per share, under a Rule 10b5-1 trading plan adopted on November 21, 2025.

Following the sale, IIM Holdings II, LLC held 34,743,361 shares. Bruce also reported additional indirect holdings through irrevocable trusts and his spouse, along with 1,151,445 shares held directly, indicating a substantial remaining position after these pre-planned transactions.

Insider Trade Summary 10b5-1

Net Seller: 227,987 shares

Net Sell 6 txns

Insider Lucas Bruce

Role Chief Executive Officer

Sold 227,987 shs ($4.32M)

Type	Security	Shares	Price	Value
Sale	Common Stock	227,987	$18.95	$4.32M
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 34,743,361 shares (Indirect, By IIM Holdings II, LLC); Common Stock — 1,151,445 shares (Direct); Common Stock — 1,362,473 shares (Indirect, By Spouse); Common Stock — 1,925,000 shares (Indirect, By Emma Cloonen Irrevocable Trust); Common Stock — 1,925,000 shares (Indirect, By Ava Cloonen Irrevocable Trust)

Footnotes (8)

1. F1. Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025.
2. F2. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.90 to $19.11 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
3. F3. The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
4. F4. Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
5. F5. The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 22,548 shares of common stock on May 27, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $18.90 to $19.11 per share.
6. F6. Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
7. F7. Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
8. F8. Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 06:01 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lucas Bruce

(Last) (First) (Middle)

C/O SLIDE INSURANCE HOLDINGS, INC.

4221 W. BOY SCOUT BLVD., SUITE 200

(Street)

TAMPA FLORIDA 33607

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/27/2026		S		227,987(1)	D	$18.95(2)	34,743,361	I	By IIM Holdings II, LLC(3)
Common Stock								1,151,445	D
Common Stock								220,000	I	By Spouse(4)
Common Stock								1,142,473(5)	I	By Spouse(6)
Common Stock								1,925,000	I	By Emma Cloonen Irrevocable Trust(7)
Common Stock								1,925,000	I	By Ava Cloonen Irrevocable Trust(8)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025.

2. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.90 to $19.11 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

3. The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

4. Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

5. The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 22,548 shares of common stock on May 27, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $18.90 to $19.11 per share.

6. Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

7. Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

8. Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

	/s/ Andy Omiridis, Attorney-in-Fact for Bruce Lucas	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)